LAG3 and neoplasm: Phase II/III MAHOGANY experiments have also demonstrated the efficacy of Tebotelima in restricting tumor growth.[77] FS118, when used in combination to block LAG-3 and PD-L1, primarily enhances the antigen cross-presentation function of DCs by promoting their maturation.